J.F. Sánchez-Ávila

5.0k total citations
50 papers, 1.0k citations indexed

About

J.F. Sánchez-Ávila is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, J.F. Sánchez-Ávila has authored 50 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hepatology, 35 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in J.F. Sánchez-Ávila's work include Liver Disease Diagnosis and Treatment (28 papers), Hepatitis C virus research (26 papers) and Hepatitis B Virus Studies (22 papers). J.F. Sánchez-Ávila is often cited by papers focused on Liver Disease Diagnosis and Treatment (28 papers), Hepatitis C virus research (26 papers) and Hepatitis B Virus Studies (22 papers). J.F. Sánchez-Ávila collaborates with scholars based in Mexico, Spain and Argentina. J.F. Sánchez-Ávila's co-authors include Florencia Vargas-Vorácková, Misael Uribe, Rafael Esteban, Marı́a Buti, Auristela Valdés, Yoav Lurie, Norberto C. Chávez‐Tapia, Lucy Dagher, David Kershenobich and M. Martell and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

J.F. Sánchez-Ávila

47 papers receiving 1.0k citations

Peers

J.F. Sánchez-Ávila
J.F. Sánchez-Ávila
Citations per year, relative to J.F. Sánchez-Ávila J.F. Sánchez-Ávila (= 1×) peers Renata de Mello Perez

Countries citing papers authored by J.F. Sánchez-Ávila

Since Specialization
Citations

This map shows the geographic impact of J.F. Sánchez-Ávila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.F. Sánchez-Ávila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.F. Sánchez-Ávila more than expected).

Fields of papers citing papers by J.F. Sánchez-Ávila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.F. Sánchez-Ávila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.F. Sánchez-Ávila. The network helps show where J.F. Sánchez-Ávila may publish in the future.

Co-authorship network of co-authors of J.F. Sánchez-Ávila

This figure shows the co-authorship network connecting the top 25 collaborators of J.F. Sánchez-Ávila. A scholar is included among the top collaborators of J.F. Sánchez-Ávila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.F. Sánchez-Ávila. J.F. Sánchez-Ávila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Menendez, Alicia, et al.. (2022). Risk factors associated with HCV co-infection amongst MSM and transgender women living with HIV in Mexico City: a case-control study. Annals of Hepatology. 27(6). 100758–100758. 2 indexed citations
2.
Fischer, Aaron J. & J.F. Sánchez-Ávila. (2021). Guillain-Barré Syndrome Following an Extended-Spectrum Beta-Lactamase Escherichia coli Urinary Tract Infection: A Case Report. Cureus. 13(11). e19673–e19673.
3.
Olivas‐Martínez, Antonio, et al.. (2021). Direct-Acting Antivirals in the Treatment of Hepatitis C Virus Recurrence after Liver Transplantation: Real-life Experience in a Mexican Cohort.. Archives of Medical Research. 52(7). 713–718. 2 indexed citations
4.
Menendez, Alicia, et al.. (2018). Características demográficas y clínicas de pacientes coinfectados por VIH y Virus de Hepatitis C en México. 294–298. 1 indexed citations
5.
Muñoz, Sergio, et al.. (2018). Manifestaciones atípicas de la infección por el virus de la hepatitis A. Revista de Gastroenterología de México. 83(2). 134–143. 9 indexed citations
6.
Dehesa, Margarita, Enrique Wolpert, Ignacio García‐Juárez, et al.. (2016). Chronic Hepatitis C Treatment with Direct-Acting Antiviral Agents in a Real-Life Setting. Revista de investigaci�n Cl�nica. 68(4). 201–209. 4 indexed citations
7.
Garay, Alejandro G Gonzalez, et al.. (2016). Pocket ultrasound device as a complement to physical examination for ascites evaluation and guided paracentesis. Internal and Emergency Medicine. 11(3). 461–466. 31 indexed citations
8.
Méndez‐Sánchez, Nahúm, Ezequiel Ridruejo, Ângelo Alves de Mattos, et al.. (2014). Latin American Association for the Study of the Liver (LAASL) Clinical Practice Guidelines: Management of Hepatocellular Carcinoma. Annals of Hepatology. 13. S4–S40. 36 indexed citations
9.
Tálamo, Carlos, et al.. (2013). Depression and excessive daytime sleepiness en obstructive sleep apnea patients. European Respiratory Journal. 42(Suppl 57). P4034–P4034. 1 indexed citations
10.
Muñoz‐Espinosa, Linda E., et al.. (2013). Re-treatment with Highly Purified nIFNα in Mexican Nonresponder Patients with Chronic Genotype 1 Hepatitis C. Archives of Medical Research. 44(6). 444–448. 1 indexed citations
12.
Chávez‐Tapia, Norberto C., Félix I. Téllez‐Ávila, Javier Lizardi-Cervera, et al.. (2009). Differential risk factor patterns for a positive treadmill test among subjects with and without ultrasound-based fatty liver. Archives of Medical Science. 5(2). 207–214. 4 indexed citations
13.
Téllez‐Ávila, Félix I., et al.. (2008). Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis. World Journal of Gastroenterology. 14(30). 4771–4771. 50 indexed citations
14.
Téllez‐Ávila, Félix I., et al.. (2007). [Therapeuric aspects of NAFLD. A literature review].. PubMed. 71(4). 487–95. 1 indexed citations
15.
Chávez‐Tapia, Norberto C., et al.. (2007). Non-Alcoholic Fatty-Liver Disease in Pediatric Populations. Journal of Pediatric Endocrinology and Metabolism. 20(10). 1059–73. 10 indexed citations
17.
Castells, Lluı́s, Helena Allende, Marı́a Buti, et al.. (2002). Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation. Liver Transplantation. 8(10). 892–900. 30 indexed citations
18.
Buti, Marı́a, R Jardí, Francisco Rodríguez‐Frias, et al.. (2001). Two years of lamivudine therapy in anti‐HBe‐positive patients with chronic hepatitis B. Journal of Viral Hepatitis. 8(4). 270–275. 41 indexed citations
19.
Buti, Marı́a, R Jardí, Albert Bosch, et al.. (2001). Valoración de la técnica de PCR-Southern blot para el análisis de la viremia en pacientes con hepatitis aguda A. Gastroenterología y Hepatología. 24(1). 1–4. 5 indexed citations
20.
Foley, Patrick, et al.. (1997). HLA-DPB1 and TAP1 Polymorphisms in Sarcoidosis. CHEST Journal. 111(6). 73S–73S. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026